BioCryst expects to begin Ebola study in weeks

(Reuters) - BioCryst Pharmaceuticals Inc said it expects to initiate a study within weeks to test its antiviral in primates for use in Ebola, as it was awarded an additional $2.4 million in U.S. government funding.

via Reuters: Health News Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://ift.tt/1C9n0zI